Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan K Shields

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Open Forum Infectious Diseases|July 7, 2017
Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug UsersDeanna J Buehrle, Ryan K Shields, Neel Shah, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Abdominal candidiasis is a hidden reservoir of echinocandin resistanceRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Microbiology Spectrum|November 10, 2021
<i>In Vitro</i> Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirAChristi L McElheny, Erin L Fowler, Alina Iovleva, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2024
Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditisSunish Shah, Lloyd Clarke, Matthew W Davis, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2025
Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia sppClayton F Hausberger, Lingyi Peng, G K Balasubramani, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuriaZubair A Qureshi, Alveena Syed, Lloyd G Clarke, et al.
The Journal of Antimicrobial Chemotherapy|March 31, 2026
Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia spp.: right-to-replySunish Shah, Clayton F Hausberger, Lingyi Peng, et al.
Anaerobe|April 8, 2010
Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literatureLucio R Minces, Ryan K Shields, Kathleen Sheridan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2022
Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa PneumoniaRyan K Shields, Madison E Stellfox, Ellen G Kline, et al.
Jac-Antimicrobial Resistance|October 5, 2023
<i>In vitro</i> activity of cefiderocol against <i>Pseudomonas aeruginosa</i> demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitorsRyan K Shields, Ellen G Kline, Kevin M Squires, et al.
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Open Forum Infectious Diseases|July 7, 2017
Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug UsersDeanna J Buehrle, Ryan K Shields, Neel Shah, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Abdominal candidiasis is a hidden reservoir of echinocandin resistanceRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Microbiology Spectrum|November 10, 2021
<i>In Vitro</i> Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirAChristi L McElheny, Erin L Fowler, Alina Iovleva, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2024
Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditisSunish Shah, Lloyd Clarke, Matthew W Davis, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2025
Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia sppClayton F Hausberger, Lingyi Peng, G K Balasubramani, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuriaZubair A Qureshi, Alveena Syed, Lloyd G Clarke, et al.
The Journal of Antimicrobial Chemotherapy|March 31, 2026
Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia spp.: right-to-replySunish Shah, Clayton F Hausberger, Lingyi Peng, et al.
Anaerobe|April 8, 2010
Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literatureLucio R Minces, Ryan K Shields, Kathleen Sheridan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2022
Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa PneumoniaRyan K Shields, Madison E Stellfox, Ellen G Kline, et al.
Jac-Antimicrobial Resistance|October 5, 2023
<i>In vitro</i> activity of cefiderocol against <i>Pseudomonas aeruginosa</i> demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitorsRyan K Shields, Ellen G Kline, Kevin M Squires, et al.
Pageof 20